| 1. | Phase 2 reaction - part 2 | 0 | |
|
| 2. | Decerebrate rigidity | 2 | |
|
| 3. | Mallory bodies versus councilman bodies - part 1 | 0 | |
|
| 4. | Cardiology - Radiology | 0 | |
|
| 5. | Syphilis- Biological false positive reactions in serologic testing | 0 | |
|
| 6. | Cardiac cycle - Duration | 0 | |
|
| 7. | Layers of epidermis | 0 | |
|
| 8. | Scurvy - Radiological features | 1 | |
|
| 9. | LGV - Lymphogranuloma vengeful | 0 | |
|
| 10. | Lumbar plexus | 0 | |
|
| 11. | Viruses - Important shapes | 0 | |
|
| 12. | Graves disease - Pathophysiology and symptoms | 0 | |
|
| 13. | Pure neuritis Hansen | 2 | |
|
| 14. | Maximum permissible radiation exposure | 0 | |
|
| 15. | Purine - Enzymes and steps | 1 | |
|
| 16. | Ribosomal assembly in prokaryotes | 0 | |
|
| 17. | Leprosy multidrug therapy - Treatment | 0 | |
|
| 18. | Distribution of coronary artery | 0 | |
|
| 19. | Immunoflourescence in dermatology | 0 | |
|
| 20. | Glomerular filtration rate GFR - Factors affecting | 0 | |
|
| 21. | Amino acid - Classification - Metabolism | 0 | |
|
| 22. | Seizures and types | 0 | |
|
| 23. | Types of enzyme inducers | 0 | |
|
| 24. | Friedrich Trendelburg - Eponyms | 0 | |
|
| 25. | Flial chest | 0 | |
|
| 26. | Woods lamp examination | 1 | |
|
| 27. | Resting membrane potential | 0 | |
|
| 28. | Factors increasing insulin secretion | 0 | |
|
| 29. | Femoral triangle | 1 | |
|
| 30. | Autism and Asperger syndrome | 0 | |
|
| 31. | Pneumothorax - Types and management | 0 | |
|
| 32. | Inclusion bodies - part 5 | 0 | |
|
| 33. | Drug effect modulations - part 1 | 0 | |
|
| 34. | Eye of tiger and humming bird sign | 0 | |
|
| 35. | Tumor markers - part 3 | 0 | |
|
| 36. | Allergic contact dermatitis | 1 | |
|
| 37. | DNA Polymerase - Type | 0 | |
|
| 38. | Corticosteroids - Diagnostic uses | 0 | |
|
| 39. | Haemostatic disorders and lab findings - part 1 | 0 | |
|
| 40. | Tissue harmonic imaging and high intensity focus | 0 | |
|
| 41. | Gullian barre syndrome - Classic signs | 0 | |
|
| 42. | Muscles of leg and anterior dorsum of foot - Innervation | 0 | |
|
| 43. | Pheochromocytoma | 0 | |
|
| 44. | Behcets disease | 0 | |
|
| 45. | Skin manifestations of diabetes mellitus | 0 | |
|
| 46. | Ocular embryogenesis | 0 | |
|
| 47. | Granuloma and associated diseases - part 1 | 0 | |
|
| 48. | M mode , CUES and Electrography | 0 | |
|
| 49. | Atrial fibrillation - Management | 1 | |
|
| 50. | Rate of reaction - Factors | 0 | |
|
| 51. | Assessment of growth | 0 | |
|
| 52. | Malignancies and translocations - part 2 | 0 | |
|
| 53. | Developmental quotient | 1 | |
|
| 54. | Skin rashes - 1 to 6 disease | 0 | |
|
| 55. | PSI - Pneumonia severity index score | 0 | |
|
| 56. | Lysosomal membrane bound spherical organelles | 0 | |
|
| 57. | Hemolytic anaemia classification - part 2 | 0 | |
|
| 58. | Parasites and common names - part 1 | 0 | |
|
| 59. | Onion eye appearance pathology - part 1 | 0 | |
|
| 60. | Organisms and selective culture media - part 1 | 0 | |
|
| 61. | Lymphatic drainage of pelvic structures | 0 | |
|
| 62. | Wilms tumor | 0 | |
|
| 63. | Golden points : Glucose transporters - part 2 | 0 | |
|
| 64. | Erythema | 0 | |
|
| 65. | Lepromatous leprosy | 0 | |
|
| 66. | Vibrio cholera culture media - part 1 | 0 | |
|
| 67. | Schedule of drugs - part 2 | 1 | |
|
| 68. | Morphine peripheral pharmacological effects | 0 | |
|
| 69. | Lymphedema | 1 | |
|
| 70. | Proximal vs distal convulated tubules | 0 | |
|
| 71. | Structure - Proteins | 0 | |
|
| 72. | Narcolepsy | 0 | |
|
| 73. | Thalamic nuclei - Divisions | 0 | |
|
| 74. | Leukodystrophy and Alexander disease | 0 | |
|
| 75. | Start and stop codons | 1 | |
|
| 76. | Anaphylaxis - Management | 0 | |
|
| 77. | Gonadotropin luteinizing hormone | 0 | |
|
| 78. | Juxtamedullary vs cortical nephron | 0 | |
|
| 79. | Excitatory post synaptic potential - EPSP | 0 | |
|
| 80. | Renal excretion | 0 | |
|
| 81. | Hailey Hailey disease | 0 | |
|
| 82. | Classical vs neonatal scabies | 0 | |
|
| 83. | Receptor binding | 1 | |
|
| 84. | Color of urine in diseases | 0 | |
|
| 85. | Ketone body - Utilisation | 0 | |
|
| 86. | Stage of concrete operations | 0 | |
|
| 87. | Arboviruses - Taxomony | 0 | |
|
| 88. | Hypospadias | 0 | |
|
| 89. | Mistakes to avoid while preparing | 1 | |
|
| 90. | Genitourinary system - Autonomic Nervous System Effects | 0 | |
|
| 91. | Gross motor milestones | 1 | |
|
| 92. | Trichotillomaia | 0 | |
|
| 93. | Chromoblastomycosis | 0 | |
|
| 94. | Breast cancer - USG | 0 | |
|
| 95. | USG - Ultrasonography | 0 | |
|
| 96. | Erythematosus multiforme | 0 | |
|
| 97. | Revised jones criteria - Acute rheumatic fever | 1 | |
|
| 98. | Skin graft | 0 | |
|
| 99. | Hypertension management - AHA guidelines American heart association | 0 | |
|
| 100. | Unsaturated Fatty acids | 0 | |
|
